Terms: = Lymphoma AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
227 results:
1. ep300-ZNF384 transactivates IL3RA to promote the progression of B-cell acute lymphoblastic leukemia.
Hou Z; Ren Y; Zhang X; Huang D; Yan F; Sun W; Zhang W; Zhang Q; Fu X; Lang Z; Chu C; Zou B; Gao B; Jin B; Kang Z; Liu Q; Yan J
Cell Commun Signal; 2024 Apr; 22(1):211. PubMed ID: 38566191
[TBL] [Abstract] [Full Text] [Related]
2. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin lymphoma.
Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
[TBL] [Abstract] [Full Text] [Related]
3. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
[TBL] [Abstract] [Full Text] [Related]
4. DUX4-r exerts a neomorphic activity that depends on GTF2I in acute lymphoblastic leukemia.
Campolungo D; Salomé M; Biferali B; Tascini AS; Gabellini D
Sci Adv; 2023 Sep; 9(37):eadi3771. PubMed ID: 37713484
[TBL] [Abstract] [Full Text] [Related]
5. YAP suppresses human T-cell leukemia virus type 1 transcription.
Li H; Zou F; Zhang J; Zhu S; Chu K; Zhang X; Zhao T
J Med Virol; 2023 Sep; 95(9):e29065. PubMed ID: 37661566
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical characteristics and outcomes of childhood B-ALL with ZNF384 and MEF2D rearrangements].
Hirabayashi S; Manabe A; Ohki K; Kiyokawa N
Rinsho Ketsueki; 2023; 64(7):633-638. PubMed ID: 37544723
[TBL] [Abstract] [Full Text] [Related]
7. BET inhibitors induce NF-κB and E2F downregulation in Hodgkin and Reed-Sternberg cells.
Fernández S; Díaz E; Rita CG; Estévez M; Montalbán C; García JF
Exp Cell Res; 2023 Sep; 430(2):113718. PubMed ID: 37468057
[TBL] [Abstract] [Full Text] [Related]
8. Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Jiménez-Ubieto A; Martín-Muñoz A; Poza M; Dorado S; García-Ortiz A; Revilla E; Sarandeses P; Ruiz-Heredia Y; Baumann T; Rodríguez A; Calbacho M; Sánchez PM; Pina JMS; García-Sancho AM; Figaredo G; Rufián L; Rodríguez M; Carneros L; Martínez-Laperche C; Bastos-Oreiro M; Wang C; Cedena MT; Rapado I; de Toledo P; Gallardo M; Valeri A; Ayala R; Martínez-López J; Barrio S
Front Immunol; 2023; 14():1188818. PubMed ID: 37342332
[TBL] [Abstract] [Full Text] [Related]
9. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
Zhu L; Bai W; Cheng Q; Fang J
Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
[TBL] [Abstract] [Full Text] [Related]
10. Efficient diagnosis of hematologic malignancies using bone marrow microscopic images: A method based on MultiPathGAN and MobileViTv2.
Yang G; Qin Z; Mu J; Mao H; Mao H; Han M
Comput Methods Programs Biomed; 2023 Jul; 237():107583. PubMed ID: 37167882
[TBL] [Abstract] [Full Text] [Related]
11. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and molecular genetic characteristics of primary gastric follicular lymphoma.
Kim H; Shin D; Son SM; Cho J; Kim JE; Kim Y; Jeon T; Ko YH
Hum Pathol; 2023 Jun; 136():114-122. PubMed ID: 37054783
[TBL] [Abstract] [Full Text] [Related]
13. Targeted therapy using larotrectinib and venetoclax for the relapsed/refractory T-cell acute lymphoblastic leukemia harboring a cryptic ETV6-NTRK3 fusion.
Zhou K; Gong D; He C; Xiao M; Zhang M; Huang W
Mol Carcinog; 2023 Jul; 62(7):899-906. PubMed ID: 37036164
[TBL] [Abstract] [Full Text] [Related]
14. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
15. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
[TBL] [Abstract] [Full Text] [Related]
16. The CRL4
Tseng C; Han Y; Lv Z; Song Q; Wang K; Shen H; Chen Z
J Mol Med (Berl); 2023 Feb; 101(1-2):171-181. PubMed ID: 36688959
[TBL] [Abstract] [Full Text] [Related]
17. Effects of the omega-3 fatty acid DHA on histone and p53 acetylation in diffuse large B cell lymphoma.
Bakhshi TJ; Way T; Muncy B; Georgel PT
Biochem Cell Biol; 2023 Apr; 101(2):172-191. PubMed ID: 36599133
[TBL] [Abstract] [Full Text] [Related]
18. Gene Expression Network and Circ_0008012 Promote Progression in MLL/AF4 Positive Acute Lymphoblastic Leukemia.
Tang YL; Su JY; Luo JS; Zhang LD; Zheng LM; Liang C; Wang LN; Li Y; Fan Z; Huang DP; Sun P; Luo Z; Qi NH; Lan JJ; Zhang XL; Huang LB; Luo XQ
Recent Pat Anticancer Drug Discov; 2023; 18(4):538-548. PubMed ID: 36503469
[TBL] [Abstract] [Full Text] [Related]
19. Analysis and therapeutic targeting of the ep300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and Hodgkin lymphoma.
Wei W; Song Z; Chiba M; Wu W; Jeong S; Zhang JP; Kadin ME; Nakagawa M; Yang Y
Leukemia; 2023 Feb; 37(2):396-407. PubMed ID: 36456744
[TBL] [Abstract] [Full Text] [Related]
20. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.
Coombes C; Horikawa K; Jain S; Jiang S; Lim JH; Saxena K; Shadbolt B; Smyth L; Tobin J; Talaulikar D
Pathology; 2023 Feb; 55(1):104-112. PubMed ID: 36420560
[TBL] [Abstract] [Full Text] [Related]
[Next]
